[Form 4] XCEL BRANDS INC. Insider Trading Activity
Filing: Form 4 filed for Xcel Brands, Inc. (XELB) with reporting person Robert D'Loren, signature dated 08/05/2025 and earliest transaction date 08/04/2025.
Roles: Reporting person is listed as Director, 10% owner and CEO and Chairman.
Transactions: The filing reports two non-derivative acquisitions on 08/04/2025: 124,200 common shares at $1.10 and 85,159 common shares at $1.38, totaling 209,359 shares acquired. The two reported rows show post-transaction beneficial ownership figures of 383,885 and 469,044 shares. An additional 60,731 shares are noted as indirectly held by the Irrevocable Trust of Rose Dempsey, over which the reporting person has sole voting and dispositive power.
Derivatives: No derivative securities are reported in Table II.
Filing: Modulo 4 presentato per Xcel Brands, Inc. (XELB) dalla persona segnalante Robert D'Loren; firma datata 08/05/2025 e data più antica della transazione 08/04/2025.
Roles: La persona segnalante è indicata come Direttore, proprietario del 10% e CEO e Presidente.
Transactions: La segnalazione riporta due acquisizioni non derivate in data 08/04/2025: 124,200 azioni ordinarie a $1.10 e 85,159 azioni ordinarie a $1.38, per un totale di 209,359 azioni acquistate. Le due righe riportano una titolarità beneficiaria post-transazione di 383,885 e 469,044 azioni. Ulteriori 60,731 azioni sono indicate come detenute indirettamente dall'Irrevocable Trust of Rose Dempsey, sul quale la persona segnalante ha il pieno potere di voto e di disposizione.
Derivatives: Nella Tabella II non sono segnalati titoli derivati.
Filing: Formulario 4 presentado para Xcel Brands, Inc. (XELB) por la persona informante Robert D'Loren; firma fechada el 08/05/2025 y fecha más temprana de la transacción 08/04/2025.
Roles: La persona informante figura como Director, propietario del 10% y CEO y Presidente.
Transactions: La presentación informa sobre dos adquisiciones no derivadas el 08/04/2025: 124,200 acciones ordinarias a $1.10 y 85,159 acciones ordinarias a $1.38, con un total de 209,359 acciones adquiridas. Las dos filas reportadas muestran tenencias beneficiarias posteriores a la transacción de 383,885 y 469,044 acciones. Además, 60,731 acciones figuran como mantenidas indirectamente por el Irrevocable Trust of Rose Dempsey, sobre el cual la persona informante tiene poder exclusivo de voto y de disposición.
Derivatives: No se informan valores derivados en la Tabla II.
Filing: Xcel Brands, Inc. (XELB)에 대한 Form 4가 보고인 Robert D'Loren에 의해 제출됨; 서명일 08/05/2025, 가장 이른 거래일 08/04/2025.
Roles: 보고인은 이사(Director), 10% 보유자 및 CEO 겸 회장으로 기재되어 있음.
Transactions: 제출서는 08/04/2025에 발생한 두 건의 비파생(Non-derivative) 취득을 보고함: 124,200 보통주를 $1.10에, 85,159 보통주를 $1.38에 취득하여 총 209,359주를 취득함. 보고된 두 항목의 거래 후 실질 소유는 각각 383,885주 및 469,044주로 표시됨. 추가로 60,731주는 Rose Dempsey의 Irrevocable Trust에 간접 보유되어 있으며, 보고인은 해당 주식에 대해 단독 의결권 및 처분권을 보유함.
Derivatives: 표 II에는 파생증권이 보고되지 않음.
Filing: Formulaire 4 déposé pour Xcel Brands, Inc. (XELB) par la personne déclarante Robert D'Loren ; signature datée 08/05/2025 et date de transaction la plus ancienne 08/04/2025.
Roles: La personne déclarante est indiquée comme Director, propriétaire de 10% et CEO et Chairman.
Transactions: Le dépôt signale deux acquisitions non dérivées le 08/04/2025 : 124,200 actions ordinaires à $1.10 et 85,159 actions ordinaires à $1.38, soit un total de 209,359 actions acquises. Les deux lignes reportées affichent des détentions bénéficiaires après transaction de 383,885 et 469,044 actions. Un complément de 60,731 actions est indiqué comme détenu indirectement par l'Irrevocable Trust of Rose Dempsey, sur lequel la personne déclarant exerce le pouvoir exclusif de vote et de disposition.
Derivatives: Aucun titre dérivé n'est déclaré dans le Tableau II.
Filing: Formular 4 eingereicht für Xcel Brands, Inc. (XELB) durch die meldende Person Robert D'Loren; Unterschrift datiert 08/05/2025 und frühestes Transaktionsdatum 08/04/2025.
Roles: Die meldende Person ist als Director, 10%-Eigentümer und CEO und Chairman aufgeführt.
Transactions: Die Einreichung berichtet über zwei nichtderivative Erwerbe am 08/04/2025: 124,200 Stammaktien zu $1.10 und 85,159 Stammaktien zu $1.38, insgesamt 209,359 erworbene Aktien. Die beiden gemeldeten Zeilen zeigen nach der Transaktion wirtschaftliches Eigentum von 383,885 bzw. 469,044 Aktien. Weitere 60,731 Aktien werden indirekt vom Irrevocable Trust of Rose Dempsey gehalten, über den die meldende Person alleinige Stimm- und Verfügungsmacht besitzt.
Derivatives: In Tabelle II sind keine derivativen Wertpapiere gemeldet.
- Insider purchases totaling 209,359 shares reported on 08/04/2025 (124,200 at $1.10 and 85,159 at $1.38)
- Reporting person holds management and ownership roles: Director, CEO and Chairman and listed as a 10% owner
- 60,731 shares are identified as indirectly held in an Irrevocable Trust with the reporting person having sole voting and dispositive power
- None.
Insights
TL;DR: Significant insider purchases by the CEO/10% owner—209,359 shares—may signal management confidence and increased insider stake.
The Form 4 records two cash-acquisition transactions on 08/04/2025 totaling 209,359 common shares at prices of $1.10 and $1.38. The reporting person is both CEO and Chairman and is designated a 10% owner, which makes these purchases strategically meaningful for ownership concentration. The filing also discloses 60,731 shares indirectly held via an Irrevocable Trust for which the reporting person has sole voting and dispositive power, reinforcing control considerations. No derivative positions are reported.
TL;DR: Insider buying increases concentrated ownership and highlights governance implications around trust-held shares and voting control.
The filing confirms that Robert D'Loren holds multiple governance roles (Director, CEO and Chairman) and is a >10% owner; the acquisitions on 08/04/2025 increase his reported beneficial holdings. The footnote disclosing 60,731 shares held by an Irrevocable Trust, with sole voting and dispositive power residing with the reporting person, is material to control analysis. Stake increases by senior management merit monitoring for board dynamics and minority shareholder impact. No derivatives or dispositions are disclosed.
Filing: Modulo 4 presentato per Xcel Brands, Inc. (XELB) dalla persona segnalante Robert D'Loren; firma datata 08/05/2025 e data più antica della transazione 08/04/2025.
Roles: La persona segnalante è indicata come Direttore, proprietario del 10% e CEO e Presidente.
Transactions: La segnalazione riporta due acquisizioni non derivate in data 08/04/2025: 124,200 azioni ordinarie a $1.10 e 85,159 azioni ordinarie a $1.38, per un totale di 209,359 azioni acquistate. Le due righe riportano una titolarità beneficiaria post-transazione di 383,885 e 469,044 azioni. Ulteriori 60,731 azioni sono indicate come detenute indirettamente dall'Irrevocable Trust of Rose Dempsey, sul quale la persona segnalante ha il pieno potere di voto e di disposizione.
Derivatives: Nella Tabella II non sono segnalati titoli derivati.
Filing: Formulario 4 presentado para Xcel Brands, Inc. (XELB) por la persona informante Robert D'Loren; firma fechada el 08/05/2025 y fecha más temprana de la transacción 08/04/2025.
Roles: La persona informante figura como Director, propietario del 10% y CEO y Presidente.
Transactions: La presentación informa sobre dos adquisiciones no derivadas el 08/04/2025: 124,200 acciones ordinarias a $1.10 y 85,159 acciones ordinarias a $1.38, con un total de 209,359 acciones adquiridas. Las dos filas reportadas muestran tenencias beneficiarias posteriores a la transacción de 383,885 y 469,044 acciones. Además, 60,731 acciones figuran como mantenidas indirectamente por el Irrevocable Trust of Rose Dempsey, sobre el cual la persona informante tiene poder exclusivo de voto y de disposición.
Derivatives: No se informan valores derivados en la Tabla II.
Filing: Xcel Brands, Inc. (XELB)에 대한 Form 4가 보고인 Robert D'Loren에 의해 제출됨; 서명일 08/05/2025, 가장 이른 거래일 08/04/2025.
Roles: 보고인은 이사(Director), 10% 보유자 및 CEO 겸 회장으로 기재되어 있음.
Transactions: 제출서는 08/04/2025에 발생한 두 건의 비파생(Non-derivative) 취득을 보고함: 124,200 보통주를 $1.10에, 85,159 보통주를 $1.38에 취득하여 총 209,359주를 취득함. 보고된 두 항목의 거래 후 실질 소유는 각각 383,885주 및 469,044주로 표시됨. 추가로 60,731주는 Rose Dempsey의 Irrevocable Trust에 간접 보유되어 있으며, 보고인은 해당 주식에 대해 단독 의결권 및 처분권을 보유함.
Derivatives: 표 II에는 파생증권이 보고되지 않음.
Filing: Formulaire 4 déposé pour Xcel Brands, Inc. (XELB) par la personne déclarante Robert D'Loren ; signature datée 08/05/2025 et date de transaction la plus ancienne 08/04/2025.
Roles: La personne déclarante est indiquée comme Director, propriétaire de 10% et CEO et Chairman.
Transactions: Le dépôt signale deux acquisitions non dérivées le 08/04/2025 : 124,200 actions ordinaires à $1.10 et 85,159 actions ordinaires à $1.38, soit un total de 209,359 actions acquises. Les deux lignes reportées affichent des détentions bénéficiaires après transaction de 383,885 et 469,044 actions. Un complément de 60,731 actions est indiqué comme détenu indirectement par l'Irrevocable Trust of Rose Dempsey, sur lequel la personne déclarant exerce le pouvoir exclusif de vote et de disposition.
Derivatives: Aucun titre dérivé n'est déclaré dans le Tableau II.
Filing: Formular 4 eingereicht für Xcel Brands, Inc. (XELB) durch die meldende Person Robert D'Loren; Unterschrift datiert 08/05/2025 und frühestes Transaktionsdatum 08/04/2025.
Roles: Die meldende Person ist als Director, 10%-Eigentümer und CEO und Chairman aufgeführt.
Transactions: Die Einreichung berichtet über zwei nichtderivative Erwerbe am 08/04/2025: 124,200 Stammaktien zu $1.10 und 85,159 Stammaktien zu $1.38, insgesamt 209,359 erworbene Aktien. Die beiden gemeldeten Zeilen zeigen nach der Transaktion wirtschaftliches Eigentum von 383,885 bzw. 469,044 Aktien. Weitere 60,731 Aktien werden indirekt vom Irrevocable Trust of Rose Dempsey gehalten, über den die meldende Person alleinige Stimm- und Verfügungsmacht besitzt.
Derivatives: In Tabelle II sind keine derivativen Wertpapiere gemeldet.